Hookworm -etiology, pathogenesis, lifecycle, diagnosis, treatment, important points

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
I now have comprehensive, multi-source data. Let me compile the complete answer.

Hookworm - Complete Overview

1. Etiology (Causative Agents)

Primary human hookworms:
SpeciesAttachment OrganGeographic PredominanceEggs/day (female)
Necator americanusCutting platesTropics/subtropics worldwide; Americas, sub-Saharan Africa, Asia5,000-10,000
Ancylostoma duodenaleBiting teeth (2 pairs)Mediterranean, Middle East, North India, China, Japan10,000-30,000
Ancylostoma ceylanicum-Southeast Asia (zoonotic - cats/dogs)-
Zoonotic species (do NOT complete life cycle in humans):
  • A. caninum (dog hookworm) - causes eosinophilic enteritis (Australia) and cutaneous larva migrans
  • A. braziliense (cat hookworm) - classic cause of cutaneous larva migrans
  • Bunostomum phlebotomum, Uncinaria stenocephala - occasional CLM
Adults measure 7-13 mm, with a dorsally curved anterior end ("hook" shape). Adults reside in the proximal small intestine (mainly jejunum).

2. Lifecycle

Hookworm Life Cycle
Step-by-step:
  1. Egg stage: Adult female worms in the small intestine produce eggs that are passed out in feces (diagnostic stage - eggs are 40x60 μm, oval, thin-shelled)
  2. Rhabditiform larva (L1/L2): In warm, moist soil (23-33°C), eggs hatch within 1-2 days into non-infective rhabditiform larvae, which undergo two molts over 5-10 days
  3. Filariform larva (L3 - infective stage): Third-stage filariform larvae develop, migrate upward on grass blades, can survive in soil for up to 1 month
  4. Skin penetration: Infective filariform larvae penetrate unprotected skin (usually feet/hands), triggering "ground itch"
    • A. duodenale can also be transmitted orally (ingested larvae survive and develop)
  5. Migration: Larvae enter venous circulation → pulmonary vasculature → penetrate alveoli → ascend bronchial tree to larynx → swallowed
  6. Intestinal development: In the small intestine, larvae molt twice more and mature into sexually mature adults
  7. Prepatent period: 6-8 weeks from skin penetration to eggs in feces (can be longer with Ancylostoma spp.)
Adult worm survival: A. duodenale ~1-14 years; N. americanus ~2-5 years

3. Pathogenesis

3a. Blood Loss - The Core Mechanism

  • Adult worms attach to intestinal villi, aspirate a plug of tissue, secrete anticoagulant and antiplatelet enzymes, and ingest blood
  • A. duodenale extracts ~0.2 mL blood/worm/day
  • N. americanus extracts ~0.03 mL blood/worm/day
  • Worms move frequently, leaving bleeding points at old attachment sites
  • Accumulated blood loss in heavy/prolonged infection leads to iron-deficiency anemia and hypoalbuminemia

3b. Three Phases of Disease

Phase 1 - Skin Entry ("Ground Itch"):
  • Pruritic erythematous maculopapular rash at site of larval penetration
  • More common with N. americanus; typically between toes or on ankles
  • Resolves spontaneously within days
Phase 2 - Pulmonary Migration (Larval Phase):
  • Dry cough, sore throat, wheezing, low-grade fever
  • Less frequent and less severe than in ascariasis
  • Transient eosinophilia
  • Loeffler-like syndrome is uncommon
Phase 3 - Intestinal/Chronic Phase:
  • Epigastric pain, abdominal bloating, abnormal peristalsis
  • Chronic iron-deficiency anemia (hypochromic microcytic) - severity depends on worm burden, dietary iron intake, concurrent blood loss
  • Hypoalbuminemia (protein-losing enteropathy) in heavy infections
  • Fatigue, weakness, exertional dyspnea
  • In children: growth retardation, cardiac failure (with severe anemia), kwashiorkor-like picture
  • In pregnant women: increased maternal/fetal morbidity (~44 million pregnant women infected globally)

3c. Immune Response

  • Elicits humoral antibody response and immediate hypersensitivity
  • Peripheral eosinophilia and gut eosinophilia
  • Eosinophils may play a role in worm destruction; however, evidence that immune responses significantly limit infection is lacking

4. Epidemiology

  • Global burden: Over 400-700 million people infected worldwide (figures vary by source)
  • Estimated 50,000-60,000 deaths/year; collectively extract over 1 million liters of blood/day from infected individuals
  • Distributed between 45°N and 30°S latitude; greatest burden in sub-Saharan Africa, Asia, and rural Americas
  • Transmission requires: feces-contaminated shady/moist soil + adequate rainfall + high temperature (23-33°C) + direct skin contact
  • Risk factors: poverty, no footwear, use of human excrement as fertilizer, poor sanitation
  • Prevalence increases through childhood, plateauing by age ~10 years; intensity peaks by age ~20 and may rise again in elderly
  • Male sex more commonly infected; women and children more vulnerable to anemia/sequelae

5. Diagnosis

MethodDetails
Stool microscopy (gold standard)Characteristic 40 x 60 μm oval, thin-shelled eggs in feces; stool concentration techniques (e.g., formalin-ether) needed for light infections
Fresh vs. old stoolOld (not fresh) stool may show hatched rhabditiform larvae - must be differentiated from Strongyloides stercoralis larvae
Species differentiationEggs of all three species are indistinguishable by light microscopy
PCRSpecies-specific; high sensitivity/specificity but remains a research tool, not commercially available
CBCHypochromic microcytic anemia; eosinophilia in larval migration phase
BiochemistryHypoalbuminemia in heavy infections
Stool egg countQuantitative Kato-Katz technique - estimates worm burden (correlates with intensity of disease)

6. Treatment

DrugDoseNotes
Albendazole400 mg once (single dose) OR 400 mg/day x 3 days3-day course preferred for N. americanus (lower single-dose efficacy)
Mebendazole500 mg single dose OR 100 mg BD x 3 daysEffective for both species
Pyrantel pamoate11 mg/kg (max 1g) x 3 daysSecond-line; less effective for N. americanus
Iron supplementationFerrous sulfateConcurrent treatment of iron-deficiency anemia
  • For cutaneous larva migrans (zoonotic hookworm): albendazole 400 mg/day x 3-5 days or ivermectin 200 μg/kg x 1-2 days
  • Albendazole single dose has lower cure rates for N. americanus than 3-day regimens
  • Treat symptomatic disease even when worm burden is light in vulnerable populations (pregnant women, children)

7. Important Points (High-Yield Summary)

  1. "Hook" shape of worm = dorsally curved anterior end; name derives from this
  2. Two cutting mechanisms: A. duodenale uses biting teeth (2 pairs), N. americanus uses cutting plates - both enable mucosal attachment and blood ingestion
  3. Infective stage = filariform (L3) larva - the diagnostic stage in stool = eggs
  4. A. duodenale is unique: larvae can also infect orally (swallowed, survive, develop directly)
  5. Ground itch = pruritic rash at skin entry site, typically between toes, more common with N. americanus
  6. A. duodenale extracts ~7x more blood per worm than N. americanus (0.2 vs 0.03 mL/day) - more anemia-inducing
  7. Eggs in old/stale stool may hatch - must distinguish rhabditiform larvae from Strongyloides (S. stercoralis has a longer buccal cavity)
  8. Cutaneous larva migrans = serpiginous, creeping track in skin from dog/cat hookworm larvae; a self-limited condition
    Cutaneous larva migrans (ground itch) - serpiginous erythematous track on foot from hookworm larval penetration
  9. Most infections are asymptomatic - disease develops only with heavy worm burden + prolonged infection + poor dietary iron
  10. Pulmonary symptoms less severe than ascariasis - remember this distinction for exams
  11. PCR for species differentiation - eggs are morphologically identical between species
  12. WHO mass drug administration (MDA) targets school-age children in endemic areas using albendazole or mebendazole
  13. Prevention: wearing footwear, sanitary disposal of feces, avoiding use of human feces as fertilizer
  14. Hyperinfection does NOT occur with hookworm (unlike Strongyloides stercoralis) - key distinguishing feature in immunocompromised patients
  15. Wakana disease (A. duodenale oral ingestion): nausea, vomiting, pharyngeal irritation, cough - follows oral ingestion of larvae

Sources: Harrison's Principles of Internal Medicine 22E (2025) - Goldman-Cecil Medicine - Sherris & Ryan's Medical Microbiology 8E - Yamada's Textbook of Gastroenterology 7E - Park's Textbook of Preventive and Social Medicine - Sleisenger & Fordtran's GI and Liver Disease
This is a shared conversation. Sign in to Orris to start your own chat.